Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/31793| Title: | One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study) | Authors: | VAN WIJMEERSCH, Bart Harrower, T. Hobart, J. Kizlaitiene, R. Marfia, G. A. Patti, F. Pearson, O. R. Van Pesch, V. Vanderdonckt, P. Vecsei, L. Shor, S. Achiron, A. |
Issue Date: | 2020 | Publisher: | WILEY | Source: | EUROPEAN JOURNAL OF NEUROLOGY, 27 , p. 1144 -1144 | Document URI: | http://hdl.handle.net/1942/31793 | Link to publication/dataset: | https://onlinelibrary.wiley.com/doi/epdf/10.1111/ene.14308 | ISI #: | WOS:000534616803153 | Rights: | 2020 European Journal of Neurology, 27 (Suppl. 1), 1018–1228 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Van_Wijmeersch_2020.pdf Restricted Access | Published version | 260.73 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.